WassonJKellerARubensteinL. Benefits and obstacles of health status assessment in ambulatory settings. The clinician’s point of view. The Dartmouth Primary Care COOP Project. Med Care1992; 30(Suppl. 5): MS42–MS49.
2.
AlbrechtG. Subjective health measurement. In: JenkinsonC (ed.) Measuring health and medical outcomes. London: UCL Press, 1994.
3.
JenkinsonC. Quality of life measurement: Does it have a place in routine clinical assessment?J Psychosom Res1994; 8: 377–381.
4.
HahnEACellaDChassanyO.; Clinical Significance Consensus Meeting Group. Precision of health-related quality-of-life data compared with other clinical measures. Mayo Clin Proc2007; 82: 1244–1254.
5.
BlackNJenkinsonC. Measuring patients’ experiences and outcomes. BMJ2009; 339: b2495.
6.
DawsonJDollHFitzpatrickR. The routine use of patient reported outcome measures in healthcare settings. BMJ2010; 340: c186.
7.
FitzpatrickRFletcherAGoreS. Quality of life measures in health care. I: Applications and issues in assessment. BMJ1992; 305: 1074–1077.
8.
ThompsonDRJenkinsonCRoebuckA. Development and validation of a short measure of health status for individuals with acute myocardial infarction: The Myocardial Infarction Dimensional Assessment Scale (MIDAS). Qual Life Res2002; 11: 535–543.
9.
WareJEKosinskiMKellerSD. A 12-item short-form health survey. Construction of scales and preliminary tests of reliability and validity. Med Care1995; 34: 220–233.
10.
WareJEJrSherbourneCD (1992) The MOS 36-item short-form health survey (SF-36) I: Conceptual framework and item selection. Med Care1992; 30: 473–483.
11.
MorleyDDummettSKellyL. The Oxford Participation & Activities Questionnaire: Study Protocol. Patient Relat Outcome Meas2014; 5: 1–6.
12.
EuroQol Group. EuroQol – a new facility for the measurement of health related quality of life. Health Policy1990; 16: 199–208.
13.
FeenyDFurlongWBoyleM. Multi-attribute health status classification systems: Health Utilities Index. Pharmacoeconomics1995; 7: 490–502.
14.
BrazierJUsherwoodTHarperR. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol1998; 51: 1115–1128.
15.
Food and Drug Administration, Department of Health and Human Sciences. Guidance to industry. Patient reported outcome measures. Use in medical product development to support labeling claims. Silver Spring, MD: Food and Drug Administration, 2009.
16.
SpeightJBarendseSM. FDA guidance on patient reported outcomes: A prompt for the industry to raise scientific standards. BMJ2010; 340: c2921.